DoorDash, in a continuing effort to broaden access to COVID-19 vaccines, tests and treatments, announced this week a new initiative to provide free delivery from Walgreens of the prescription Paxlovid, a proven COVID-19 treatment, to people living in underserved communities across the U.S.
The initiative, which will be rolled out in the coming weeks, is expected to include New Jersey.
The company said it is answering President Joe Biden’s call to action.
In addition to free delivery of Paxlovid, an oral COVID-19 medication that can reduce the risk of hospitalization and death, the company said it is delivering free COVID tests to those at risk in certain areas, including the greater New York City area.
Through this new initiative, patients with a prescription for Paxlovid being filled at Walgreens will be able to have their medication delivered directly to their homes through DoorDash at no additional cost.
DoorDash officials say this is especially crucial for seniors and people who live in socially vulnerable communities. Eligible consumers will be able to access free same-day delivery of Paxlovid via Walgreens.com and the Walgreens app, with contactless delivery powered by Drive — DoorDash’s white-label fulfillment platform that powers direct delivery for any business.
Elizabeth Jarvis-Shean, vice president of communications and policy at DoorDash, said the company is eager to do its part to help.
“DoorDash is proud to again respond to the White House’s call to action and partner with Walgreens to expand access to life-saving COVID-19 treatments ahead of the winter months,” she said.
“The pandemic has shown the urgent need for collaboration across the public and private sectors, and we look forward to working with our partners at Walgreens to ensure that those who need these critical COVID-19 treatments can access them in an equitable way.
“We remain committed to empowering local economies and expanding access so that, together, we can better protect the health of our communities.”